To add a bio or update investment portfolio click update information.
Transpose Platform: Investment Portfolio & Startup News
Transpose Platform
Investment Portfolio


QuantrolOx raises a £10m Series A round led by IW Capital for software that automates quantum computer operations
QuantrolOx develops machine learning software that automates the tuning, control and optimisation of quantum computers across different hardware architectures. Quantum EDGE, QuantrolOx’s hardware-agnostic platform, supports calibration, characterisation and tuning for research labs and quantum hardware partners.


Pharosyn secures £2.2m in funding led by Moonfire to improve commercial decision-making inside pharma companies
Pharosyn builds custom AI infrastructure for commercial decision-making in pharmaceutical companies. Embedded directly inside pharma teams, the infrastructure increases the depth of insight, scope of analysis and speed at which those teams can work, helping them decide where to allocate resources.


Mutable Tactics lands a £1.6m pre-seed round led by Seraphim Space for autonomous drone coordination when communications fail
Mutable Tactics develops software that enables unmanned systems such as aerial, maritime and ground drones to operate and coordinate even when communications or GPS are unreliable. Its decision-layer software translates a commander’s intent into locally executable actions so multiple drones can operate together as a coordinated team.


The Bland Company lands a £2m pre-seed led by Initialized Capital to turn overlooked agriculture byproducts into food proteins
The Bland Company produces functional food proteins from agricultural side streams using a biochemical process that works with existing manufacturing equipment. Its ingredients are designed for food manufacturers to replace eggs while maintaining texture, binding, and emulsifying performance.
More venture news
- 18 Nov 2026

BoltzBoltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
Series ALife Sciences - 16 Nov 2026

ZyaZya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
Series AHealth - 13 Nov 2026

Oyster TherapeuticsOyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
Series ALife Sciences